Back to Agenda
Session 1: Different Perspectives on Unmet Medical Need
Session Chair(s)
Claudine Sapède, PharmD
Director, Global HTA Policy
NOVARTIS INTERNATIONAL, Switzerland
Speaker(s)
A Patient’s Perspective: François Houyez
Treatment Information and Access Director, Health Policy Advisor
European Organisation for Rare Diseases (EURORDIS), France
A Regulator’s Perspective: Michael Berntgen, PhD
Head of Scientific Evidence Generation
European Medicines Agency, Netherlands
An HTA Body’s Perspective : Antje Behring, PharmD, PhD
Head, Early Benefit Assessment, Pharmaceuticals Department
Federal Joint Committee (G-BA), Germany
Have an account?